Anti-HBV specific beta-L-2'-deoxynucleosides. - Wikidata - wikimedia - TriplyDB

Anti-HBV specific beta-L-2'-deoxynucleosides.

Anti-HBV specific beta-L-2'-deoxynucleosides.

http://www.wikidata.org/entity/Q34373564

about

The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection Telbivudine: an upcoming agent for chronic hepatitis B.Targets of emerging therapies for viral hepatitis B and C.Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.Synthesis, antiviral activity, cytotoxicity and cellular pharmacology of l-3'-azido-2',3'-dideoxypurine nucleosides.Synthesis, physicochemical and pharmacokinetic studies of potential prodrugs of beta-L-2'-deoxycytidine, a selective and specific anti-HBV agent.Telbivudine: a hepatitis B-specific antiviral.Rapid access to 2'-branched-carbocyclic nucleosides and their 4'-epimers from 2-alkyl-cyclopentene-1-ones.

P2860

Q33787525-C5D4EF1B-31CC-4C77-9AAB-58CAE85E4EE1 Q36233495-D0DBED4A-607A-4D0B-8924-1B4999A09F10 Q36653655-6BA8E31E-03E5-4424-9AC2-2C496F9A73F1 Q38071400-CA8B4D2F-BE50-42D4-BF68-CD3E185AEB5F Q39519226-DC58B26C-F6AC-4E0C-AFE6-D6ADA6C3C6C8 Q45145073-70B6D5C2-62F9-47C2-AAAE-4B781B0352A3 Q45253502-A410F022-9074-4F13-99CE-532AAC077F2D Q46773284-7E1A0556-3D94-49CD-A99D-96E54E18163B

P2860

Anti-HBV specific beta-L-2'-deoxynucleosides.

http://www.wikidata.org/entity/Q34373564

description

2001 nî lūn-bûn

@nan

2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

Anti-HBV specific beta-L-2'-deoxynucleosides.

@ast

Anti-HBV specific beta-L-2'-deoxynucleosides.

@en

Anti-HBV specific beta-L-2'-deoxynucleosides.

@nl

type

label

Anti-HBV specific beta-L-2'-deoxynucleosides.

@ast

Anti-HBV specific beta-L-2'-deoxynucleosides.

@en

Anti-HBV specific beta-L-2'-deoxynucleosides.

@nl

prefLabel

Anti-HBV specific beta-L-2'-deoxynucleosides.

@ast

Anti-HBV specific beta-L-2'-deoxynucleosides.

@en

Anti-HBV specific beta-L-2'-deoxynucleosides.

@nl

P1433

Q34373564-5E1DD8B7-15A7-4F46-800F-64CEF338B6A3

P1476

Q34373564-F35DFA48-5C3B-4C90-A624-1E9FCCADECD9

P2093

Q34373564-1E5EAD12-BE28-4821-8DC8-654E4FEE6047

Q34373564-1FE36690-0AB1-485D-B13B-5F1D3492156E

Q34373564-2041033F-9650-441A-B375-66A5BC7CCB07

Q34373564-398A4C22-C712-4E87-978C-0B764F8259A1

Q34373564-3B700252-219E-4F0F-9269-D5648A495674

Q34373564-7214E539-139C-4287-8D4B-D3FD9F83A30E

Q34373564-73DB1739-741B-4DDE-8FD3-736DFBEA99F3

Q34373564-7702F1C6-D4D0-4601-B899-BB26E1585D2E

Q34373564-7A6E58E5-2BE8-429A-9739-D498FE3457A5

Q34373564-97DA5228-DD79-4CD4-8EC5-D0ABAB17F7F4

P2860

Q34373564-0467DBA2-A6C3-4C47-8C01-D674A8D5E617

Q34373564-178792CF-331C-460D-B786-A218AE35CFAA

Q34373564-26722D24-55A6-4355-B34C-DB41A75E82D7

Q34373564-2B07DD5E-4AC0-4B57-BB7B-E0E247290530

Q34373564-35390C0B-68B4-4A77-8B35-CA8A6614FA1C

Q34373564-3A98D1DE-A2E4-43C0-8B40-9C2EC76BE737

Q34373564-4843E7B3-CE3C-4DB0-B086-5CEF6A381ED4

Q34373564-4E87111C-0116-49A5-8FF4-15DE545E6E54

Q34373564-4EE7966C-1485-40B1-8312-FC5EF28BD50C

Q34373564-57E968E3-FB40-47A9-971E-17C84F8AC872

P304

Q34373564-4BDA6FF2-9A3B-43BD-A436-599219FCA7E6

P31

Q34373564-AC775FF5-AFAE-49FB-8BC7-151BC0C936E2

P356

Q34373564-4754515E-2F6B-42CA-A28B-7BEE6AB4C381

P433

Q34373564-28F34AA4-9BAC-420F-8A0D-08C6E926511F

P478

Q34373564-44F30E18-9043-4A60-8AAA-E1EE418F611C

P577

Q34373564-7CE8AFC8-3BA5-4DE3-AB86-B56C953C9AD5

P698

Q34373564-5DEEB26D-2E1C-4276-96AB-3FEE1B4A47E4

P356

P1433

Nucleosides, Nucleotides & Nucleic Acids

P1476

Anti-HBV specific beta-L-2'-deoxynucleosides.

@en

P2093

Bridges EG

http://www.w3.org/2001/XMLSchema#string

Bryant ML

http://www.w3.org/2001/XMLSchema#string

Cote P

http://www.w3.org/2001/XMLSchema#string

Cretton-Scott E

http://www.w3.org/2001/XMLSchema#string

Dukhan D

http://www.w3.org/2001/XMLSchema#string

Faraj A

http://www.w3.org/2001/XMLSchema#string

Gosselin G

http://www.w3.org/2001/XMLSchema#string

Hernandez B

http://www.w3.org/2001/XMLSchema#string

Imbach JL

http://www.w3.org/2001/XMLSchema#string

Juodawlkis A

http://www.w3.org/2001/XMLSchema#string

P2860

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

Mitochondrial myopathy caused by long-term zidovudine therapy

Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine

Intracellular metabolism of beta-L-2',3'-dideoxyadenosine: relevance to its limited antiviral activity

Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase

Stavudine: an update of its use in the treatment of HIV infection.

Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells.

Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS).

Didanosine. A review of its antiviral activity, pharmacokinetic properties and therapeutic potential in human immunodeficiency virus infection.

P304

597-607

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1081/NCN-100002336

http://www.w3.org/2001/XMLSchema#string

P433

4-7

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2001-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11563077

http://www.w3.org/2001/XMLSchema#string